Drugs / [131]I-IAZA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03427320 | Dec 2018 → Apr 2021 | metastatic neoplasm | University of Alberta | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [131]I-IAZA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03427320 ↗ |
| Modality | Diagnostic / imaging agent | “A \[131\]I-IAZA scan is a nuclear medicine test used to create pictures of the whole body” NCT03427320 ↗ |
| Route | Intravenous | “\[131\]I-IAZA is injected into a vein” NCT03427320 ↗ |